NASDAQ-listed company 180 Life Sciences $ATNF announced that it has signed a PIPE private sale protocol, planning to raise $425 million.



To execute the $ETH strategic plan, the new company will be renamed #ETHZilla# .
The issue price is $2.65 per share, expected to be completed on August 1, 2025.

After the announcement was released, 180 Life Sciences' stock price opened high and then fell, peaking above $4.7, and is currently reported at $2.7, a 43% retracement from its high.

180 Life Sciences also plans to issue bonds of up to $150 million.

Electric Capital will act as the external asset manager, designing high-yield DeFi strategies.

Exceeds traditional ETH staking yields, such as staking, lending, LP, etc.

There are more than 60 PIPE investors, covering traditional financial and crypto-native institutions, including:
Electric Capital, Polychain Capital, GSR, Omicron, and Lido co-founder Konstantin Lomashuk, Eigen Layer founder Sreeram Kannan, Silagadze, Frax co-founder Sam Kazemian, Compound founder Robert Leshner, Gauntlet founder Tarun Chitra, among others.

A rough look shows that most of the investors are the founders of DeFi protocols, and they are expected to be upstream and downstream partners of ETHZilla.
ETH2.19%
DEFI-1.62%
EIGEN3.82%
FRAX6.7%
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)